Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...
Read Full NewsDr Bradley Corr reviews data on the NRG-GY019 and ROSELLA trials, and discusses their clinical impact on ovarian cancer care.
Up to 15 million Americans are at risk of heart failure, with mortality rates rising in the US.
New data show strong links between chronic disease, sexual dysfunction, and loneliness, highlighting missed opportunities for holistic patient evaluation.
The U.S. Supreme Court temporarily reinstated on Monday a federal rule allowing the abortion pill to be prescribed through telemedicine and dispensed through the mail,...
Retirement's a critical window: Boredom, pain, and social withdrawal can push older patients toward alcohol or drugs. Doctors should screen, counsel, and refer to tailored services.
Customizable waveforms in a wearable stimulation device were associated with higher responder rates than standard settings in new research.
Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.
1.
Childhood brain tumors develop early in highly specialized nerve cells, research reveals
2.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
3.
FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.
4.
Obesity-related cancers are more likely in people who are obese in both healthy and unhealthy ways.
5.
Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness
1.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
2.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
3.
Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence
4.
Exosomes in Cancer: A Novel Frontier for Therapy and Biomarker Discovery
5.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
5.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge